Drug in­spec­tor at­tri­tion leads to 'many few­er' checks than 2016 peak, GAO says

The US Gov­ern­ment Ac­count­abil­i­ty Of­fice pub­lished a new re­port de­tail­ing con­cerns with the staffing of the FDA’s drug in­spec­tion pro­gram, and the fact that the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER